Biolinerx LTD

20-F13G

Schedule 13G - Passive Investments

NASDAQ
Highbridge Capital Management, LLC has disclosed a 7.2% beneficial ownership stake in BioLineRx Ltd., primarily through warrants convertible into Ordinary Shares.
NASDAQ
A group comprising Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC has disclosed a 4.99% passive beneficial ownership stake in BioLineRx Ltd. as of January 10, 2025, following a recent Securities Purchase Agreement.
Capital raise